Feeding Disorder Treatment Programs Urgently Needed for Children with Autism

Eating problems beyond picky eating are “exceedingly common” among children. Children with autism spectrum disorder are even more impacted, with around 70% of children with autism having some level of food selectivity.  Yet many children with autism fail to receive timely care for feeding problems because of hurdles with health insurance or prohibitive distance from […]

Massive Federal Opioid Trial Falls Short of Overdose Death Reduction Goals

An ambitious federal trial to curb opioid-related deaths by using community interventions came up short.  Despite the implementation of public education campaigns, increased naloxone distribution and improved access to medications for opioid use disorder (MOUD), as well as many other interventions, the trial failed to demonstrate a statistically significant reduction in overdose deaths. The large-scale […]

Payable Hours for Training, Clear Career Tracks Help Retain Autism Therapy Staff 

With autism therapy professionals in high demand and in short supply, organizations are getting creative to hold onto their employees. From conducting “stay interviews” to glean job satisfaction insights to offering reliable schedules and growth opportunities, providers are pulling out all the stops to prevent clinician burnout and keep top talent on board. Demand for […]

Emergency Rooms Emerge as Critical Entry Point for Substance Use Disorder Care

The emergency department (ED) can be the “first, and sometimes only” interaction that people with substance use disorders (SUDs) have with the health care system. Integrating SUD care into EDs can connect these patients to crucial long-term care. Still, co-occurring conditions, stigma and polysubstance use are among the main barriers preventing efficient integration. The ED […]

Headspace Targets College Students With Uwill Partnership

Digital mental health app Headspace is expanding its reach to college students through a new partnership, its latest in a series of collaborations with specialty providers and tech organizations. Headspace partnered with Uwill, a digital mental health platform that specifically caters to colleges and universities. The deal made Uwill Headspace’s exclusive partner in higher education. […]

Gateway CEO: Pre-Admission Requirements Could Violate Parity Laws

Payers often prefer ambulatory, outpatient substance use disorder (SUD) treatment for its lower cost. Yet, SUD patients frequently present with higher acuity cases and more co-occurring conditions. Gateway Foundation is preparing for both trends by making targeted investments in ambulatory and bedded programs while also battling increased pre-admission requirements from payers. In some instances, these […]

Is Venture Capital Ready for Brick-and-Mortar Behavioral Health Investment? 

Private equity has long dominated in-person behavioral health investment. But some venture capital investors, who entered the behavioral health market by backing digital providers, have now moved into hybrid business models that include both telehealth and in-person elements. For example, GV, formerly Google Ventures, recently invested in hybrid outpatient provider Guidelight. Despite the higher working […]

How LifeStance Is Prepping for Potential Telehealth Regulation Changes, Installing Collaborative Care Models

Collaborative care has gained significant traction in the behavioral health industry since its inception in the early 2000s. The care model, which integrates physical and behavioral health care services, is set to become the gold standard, according to Dr. Ujjwal Ramtekkar, chief medical officer of LifeStance Health. LifeStance is increasingly implementing collaborative care across its […]

FDA Panel’s Rejection of MDMA Is ‘Speed Bump, Not Stop Sign,’ for Psychedelic Industry

The psychedelic industry learned important lessons when a Food and Drug Administration advisory committee voted to reject a landmark MDMA-based therapy designed to treat PTSD. The rejection shook investors and demonstrates that FDA approval for novel psychedelic drugs is further away than previously thought, but industry insiders remain confident in the industry’s long-term success. The […]